CNS Pharmaceuticals Inc.
13F holders, Q4 2024 (December 31)21holders +7
8new positions
3sold out
1famous investor
$0.12avg. 13F price*
At the end of Q4 2024, 21 institutions reported holding CNS Pharmaceuticals Inc. in their 13F filings, up 7 from Q3 2024. 8 opened new positions and 3 sold out. The largest holders were Jane Street Group, LLC ($51K), Geode Capital Management, LLC ($47K) and Citadel Advisors ($39K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- CNS Pharmaceuticals Inc.
- CUSIP
- 18978H300
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $168K |
| Exits | 3 | $2K |
All 13F filers, Q3 2024 → Q4 2024: 2,030,205 shares bought and 134,148 shares sold, net +1,896,057 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Jane Street Group, LLC | 0.00% | Add +1712.3% | 419,737 | $51K |
| Geode Capital Management, LLC | 0.00% | Add +90.5% | 387,064 | $47K |
| Citadel Advisors | 0.00% | New | 321,874 | $39K |
| XTX Topco Ltd | 0.00% | New | 294,919 | $36K |
| Connective Capital Management, LLC | 0.04% | New | 280,055 | $34K |
| Integrated Wealth Concepts LLC | 0.00% | New | 250,000 | $30K |
| Virtu Financial LLC | 0.00% | Add +32.1% | 162,349 | $20K |
| HRT Financial LP | 0.00% | New | 156,007 | $18K |
| Two Sigma Investments, LP | 0.00% | New | 93,077 | $11K |
| UBS Group AG | 0.00% | Reduce -64.6% | 64,418 | $8K |
| Goldman Sachs Group Inc. | 0.00% | Add +43.0% | 40,329 | $5K |
| MAI Capital Management | 0.00% | New | 2,000 | $241 |
| Bank of America Corp. | 0.00% | Add +88.0% | 440 | $53 |
| SBI Securities Co., Ltd. | 0.00% | — | 105 | $13 |
| Synergy Investment Management, LLC | 0.00% | — | 9 | $1 |
| Wells Fargo & Company | 0.00% | No change | 4 | $0 |
| Danske Bank A/S | 0.00% | No change | 2 | $0 |
| Plante Moran Financial Advisors, LLC | 0.00% | No change | 1 | $0 |
| Parallel Advisors, LLC | 0.00% | No change | 1 | $0 |
| Global Retirement Partners, LLC | 0.00% | Reduce -50.0% | 1 | $0 |
| Dogwood Wealth Management LLC | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is CNS PHARMACEUTICALS INC's weight in each manager's 13F, not the share of CNS Pharmaceuticals Inc. the manager owns.